What is Revvity?
Revvity is a life sciences and diagnostics tools company serving enterprise, public-sector, commercial, consumer, or regulated-market customers.
- Category
- Life sciences and diagnostics tools
- Headquarters
- Waltham, MA
- Founded
- See official company history
- Employees
- See latest annual report and company filings
- Total funding
- Public company
- Status
- Public company; NYSE: RVTY
What is Revvity?
Revvity is a life sciences and diagnostics tools company headquartered in Waltham, MA. Its public-company profile is most useful for account planning when combined with current filings, investor materials, job posts, product launches, and partner announcements.
Revvity is a life sciences and diagnostics tools company headquartered in Waltham, MA. Its public-company profile is most useful for account planning when combined with current filings, investor materials, job posts, product launches, and partner announcements.
For sellers, Revvity should be mapped as a scaled public-company account rather than an early-stage company. The best timing signals are earnings commentary, capital spending, hiring clusters, product launches, acquisitions, facility investments, and leadership changes.
What does Revvity offer?
Revvity's profile centers on Life science reagents, Diagnostics, Informatics, Automation.
- Life science reagents· Life sciences and diagnostics tools
- Diagnostics· Life sciences and diagnostics tools
- Informatics· Life sciences and diagnostics tools
- Automation· Life sciences and diagnostics tools
- Cell and gene therapy tools· Life sciences and diagnostics tools
- Screening platforms· Life sciences and diagnostics tools
How does Revvity make money?
Revvity makes money through commercial activity tied to life sciences and diagnostics tools.
Revvity monetizes through the model common to life sciences and diagnostics tools: product sales, recurring services, subscriptions, contracts, distribution, transaction volume, underwriting, regulated utility revenue, or usage depending on the operating unit.
Sales angles should connect to measurable priorities such as margin, growth, uptime, compliance, retention, automation, risk reduction, data quality, customer experience, or field productivity.
Who leads Revvity?
Revvity's named executives should be verified on the official leadership or investor-relations page before outreach.
- Revvity executive leadershipExecutive leadership teamCurrent as of June 2026Use the official leadership, governance, or investor-relations page for current named executives before outreach.
- Revvity finance leadershipFinance / CFO organizationCurrent as of June 2026Often owns investor communication, procurement governance, capital allocation, and budget discipline.
- Revvity operations or technology leadershipOperations, product, technology, security, or commercial leadershipCurrent as of June 2026Likely stakeholder group for software, infrastructure, data, workflow, and operating-improvement purchases.
How do you contact Revvity's leadership?
Revvity should be contacted through official investor, media, partner, support, or sales routes unless a named executive publishes a direct address.
contact via https://www.revvity.comHow is Revvity funded?
Revvity's current status is Public company; NYSE: RVTY.
Revvity's capital profile is best understood through its current public-company status: Public company; NYSE: RVTY. For public companies, financing and budget signals are usually found in annual reports, quarterly results, debt disclosures, buybacks, acquisitions, capex plans, and management commentary rather than venture funding rounds.
Before outreach, verify the latest status on the company's investor-relations page and current exchange filings.
How did Revvity get here?
Revvity's history should be read through founding, scale-up, public-market ownership, and current product or market focus.
- FoundingRevvity is foundedThe company begins building in life sciences and diagnostics tools.
- Scale-upCommercial footprint expandsRevvity broadens its product, customer, distribution, or geographic reach.
- Public marketsPublic company; NYSE: RVTYPublic-company ownership shapes reporting, procurement, and operating priorities.
- 2025Scaled operating profileThe company operates with specialized teams and repeatable buying centers.
- June 2026Current profile refreshedProfile generated from official domain, public-company status, and source references.
Who are Revvity's competitors?
Revvity competes with larger incumbents and focused specialists in life sciences and diagnostics tools.
- Thermo Fisher ScientificLife sciences tools, diagnostics, and services incumbent.
- DanaherLife sciences and diagnostics platform company.
- MedtronicGlobal medical technology competitor.
- PfizerLarge pharmaceutical company with global commercial reach.
- IQVIAHealthcare data and clinical research platform competitor.
Revvity — frequently asked questions
